1. Home
  2. IVA vs OVBC Comparison

IVA vs OVBC Comparison

Compare IVA & OVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • OVBC
  • Stock Information
  • Founded
  • IVA 2011
  • OVBC 1872
  • Country
  • IVA France
  • OVBC United States
  • Employees
  • IVA N/A
  • OVBC N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • OVBC Major Banks
  • Sector
  • IVA Health Care
  • OVBC Finance
  • Exchange
  • IVA Nasdaq
  • OVBC Nasdaq
  • Market Cap
  • IVA 117.3M
  • OVBC 116.8M
  • IPO Year
  • IVA 2020
  • OVBC N/A
  • Fundamental
  • Price
  • IVA $2.35
  • OVBC $24.80
  • Analyst Decision
  • IVA Strong Buy
  • OVBC
  • Analyst Count
  • IVA 4
  • OVBC 0
  • Target Price
  • IVA $13.25
  • OVBC N/A
  • AVG Volume (30 Days)
  • IVA 9.3K
  • OVBC 6.1K
  • Earning Date
  • IVA 09-25-2024
  • OVBC 01-23-2025
  • Dividend Yield
  • IVA N/A
  • OVBC 3.55%
  • EPS Growth
  • IVA N/A
  • OVBC N/A
  • EPS
  • IVA N/A
  • OVBC 2.46
  • Revenue
  • IVA $20,652,523.00
  • OVBC $57,340,000.00
  • Revenue This Year
  • IVA N/A
  • OVBC N/A
  • Revenue Next Year
  • IVA $361.78
  • OVBC N/A
  • P/E Ratio
  • IVA N/A
  • OVBC $10.07
  • Revenue Growth
  • IVA N/A
  • OVBC 3.72
  • 52 Week Low
  • IVA $1.53
  • OVBC $19.35
  • 52 Week High
  • IVA $4.75
  • OVBC $28.00
  • Technical
  • Relative Strength Index (RSI)
  • IVA 36.64
  • OVBC 36.80
  • Support Level
  • IVA $2.22
  • OVBC $26.03
  • Resistance Level
  • IVA $2.39
  • OVBC $27.35
  • Average True Range (ATR)
  • IVA 0.10
  • OVBC 1.02
  • MACD
  • IVA -0.03
  • OVBC -0.35
  • Stochastic Oscillator
  • IVA 24.76
  • OVBC 7.02

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services within Southeastern Ohio as well as western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers and other standard banking products and services. The bank segmented its operating activities into two reportable segments, Banking and Consumer Finance. The majority of its total revenue is derived from the Banking segment.

Share on Social Networks: